131 results
Page 4 of 7
8-K
EX-99.1
lwv0u6ug3zgv
3 Jun 19
Other Events
4:02pm
8-K
EX-99.1
9xme zst0yf4s
15 May 19
Achieved its Primary Endpoint in Previously Treated IDH1 Mutant Cholangiocarcinoma
4:13pm
8-K
EX-99.1
03fhxvas5 dw4
2 May 19
Other Events
3:24pm
8-K
EX-3.1
7btzqm4fp9p7
19 Dec 18
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
EX-99.1
2n93k0o
3 Dec 18
Other Events
4:03pm
8-K
EX-99.2
mhyfmicq2b ms
3 Dec 18
Other Events
4:03pm
8-K
EX-99.1
pxk36
16 Nov 18
Agios Presents Updated Data from Phase 1 Dose-Escalation Study ofAG-881 in Patients with IDH Mutant Positive Advanced Glioma
4:01pm
8-K
EX-99.1
ogl81sqx5 6fjr
20 Jul 18
FDA Grants Approval of TIBSOVO®, the First Oral, Targeted Therapy for Adult Patients
11:21am
8-K
EX-99.2
ywzkimj
4 May 18
Results of Operations and Financial Condition
7:07am